T 1020/11 (PCV2 combination vaccine/BOEHRINGER INGELHEIM) of 07.04.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T102011.20160407
- Date of decision
- 7 April 2016
- Case number
- T 1020/11
- Petition for review of
- -
- Application number
- 06848471.6
- IPC class
- A61K 39/04A61K 39/12A61K 39/295
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Multivalent PCV2 immunogenic compositions and methods of producing such compositions
- Applicant name
- Boehringer Ingelheim Vetmedica, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 84
- Keywords
- Main request
Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Claims - clarity (yes) - Catchword
- -
- Cited cases
- T 1021/11
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution on the basis of the claims of the main request filed on 6 April 2016.